King Garry, Hunt Linda P, Wilkinson J Mark, Blom Ashley W
a University of Bristol ; Bristol .
b University of Sheffield , Sheffield , UK.
Acta Orthop. 2016;87(2):93-9. doi: 10.3109/17453674.2015.1137439. Epub 2016 Feb 10.
People with cerebral palsy (CP) often have painful deformed hips, but they are seldom treated with hip replacement as the surgery is considered to be high risk. However, few data are available on the outcome of hip replacement in these patients.
We linked Hospital Episode Statistics (HES) records to the National Joint Registry for England and Wales to identify 389 patients with CP who had undergone hip replacement. Their treatment and outcomes were compared with those of 425,813 patients who did not have CP. Kaplan-Meier estimates were calculated to describe implant survivorship and the curves were compared using log-rank tests, with further stratification for age and implant type. Reasons for revision were quantified as patient-time incidence rates (PTIRs). Nationally collected patient-reported outcomes (PROMS) before and 6 months after operation were compared if available. Cumulative mortality (Kaplan-Meier) was estimated at 90 days and at 1, 3, and 5 years.
The cumulative probability of revision at 5 years post-surgery was 6.4% (95% CI: 3.8-11) in the CP cohort as opposed to 2.9% (CI 2.9-3%) in the non-CP cohort (p < 0.001). Patient-reported outcomes showed that CP patients had worse pain and function preoperatively, but had equivalent postoperative improvement. The median improvement in Oxford hip score at 6 months was 23 (IQR: 14-28) in CP and it was 21 (14-28) in non-CP patients. 91% of CP patients reported good or excellent satisfaction with their outcome. The cumulative probability of mortality for CP up to 7 years was similar to that in the controls after stratification for age and sex.
Hip replacement for cerebral palsy appears to be safe and effective, although implant revision rates are higher than those in patients without cerebral palsy.
脑瘫(CP)患者常伴有疼痛性髋关节畸形,但由于手术被认为风险较高,很少接受髋关节置换治疗。然而,关于这些患者髋关节置换结果的数据很少。
我们将医院事件统计(HES)记录与英格兰和威尔士国家关节注册中心的数据相链接,以识别389例接受髋关节置换的CP患者。将他们的治疗情况和结果与425813例非CP患者进行比较。计算Kaplan-Meier估计值以描述植入物的生存率,并使用对数秩检验比较曲线,同时按年龄和植入物类型进行进一步分层。翻修原因以患者时间发病率(PTIR)进行量化。如有可用数据,比较全国收集的患者手术前后6个月的报告结局(PROMS)。估计术后90天、1年、3年和5年的累积死亡率(Kaplan-Meier)。
CP队列术后5年的累积翻修概率为6.4%(95%CI:3.8-11),而非CP队列的这一概率为2.9%(CI 2.9-3%)(p<0.001)。患者报告结局显示,CP患者术前疼痛和功能较差,但术后改善程度相当。CP患者术后6个月牛津髋关节评分的中位数改善为23(IQR:14-28),非CP患者为21(14-28)。91%的CP患者对其治疗结果表示满意或非常满意。在按年龄和性别分层后,CP患者7年的累积死亡概率与对照组相似。
脑瘫患者的髋关节置换似乎是安全有效的,尽管植入物翻修率高于非脑瘫患者。